Home > Drug Search >
  • company_query: Asklepios BioPharmaceutical (AskBio)
  •   > 
Drug Filter
Category:
chemistry (10) biology (14)
Status:
Approved (2) Phase Ⅲ (3) Phase Ⅱ (10) Phase Ⅰ (9)
Clinical Stage:
Pending (3) Active (16) Discontinued (3)
Bio-Type:
Gene therapy (1) CAR T cell therapy (5) Vaccine (2) Whole antibody (3) ADC (1) Fusion protein (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (2) Attention deficit hyperactivity disorder (ADHD) (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Diarrhea (1) Gastric cancer (1) Leukemia (1) Major depressive disorder (MDD) (1) Melanoma (2) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (2) Non-Hodgkin’s lymphoma (NHL) (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Peptic ulcer (1) Solid tumours (2) Head and neck cancer (1) Colorectal cancer (1) Neuroblastoma (1) Age-related macular degeneration (AMD) (2) Pain (2) Diagnostic agents (1) Type 1 diabetes (1) Hemophilia B (1) Renal carcinoma (1) Peritoneum cancer (1) Alcoholism (1) Vasomotor symptoms (1) Neurological disease (1) Ebola virus disease (EVD) (2) Immunological disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top